There has been no actual clinical report on the changes in bone turnover markers and bone mineral density (BMD) during ibandronate (IBN) treatment with or without vitamin D in Japanese ... osteoporotic patients were…
This work aims to investigate the changing characteristics of calcium-regulating hormones and bone turnover markers (BTMs) among Han-Chinese men in a Beijing community. A retrospective analysis was carried ... calcium-…
VSMCs Trans differentiation to phenotypic osteoblastic cells. In addition, patients with CKD usually have bone turnover problems. For a high turnover status, secondary hyperparathyroidism increases calcium and phosphate…
Background: This study was designed to describe Bone Turnover Marker (BTM) profiles in women. Patients and methods: In all, 197 patients (age 61 (36-90) years) comprising five groups were ... studied: Osteoporosis with…
year to take place, without any role in therapy monitoring. Biochemical markers of bone turnover are early indicators of bone loss, fracture risk and intervention threshold. Osteopontin, a glycoprotein ... implicated in…
with type 2 diabetes mellitus (T2DM), characterised by altered bone mineral density (BMD) and bone turnover marker (BTMs) levels. The impact of different anti-diabetic medications on the skeleton remains
causing adverse effects on bone mineral density (BMD), especially on the pediatric skeletal system. Bone turnover markers (BTMs) are used to assess bone health due to their fracture prediction ability
blood and increase bone resorption by osteoclasts. Both causes the increase of bone turnover and as risk factors that increase osteoporosis prevalence in the women population during the menopausal transition ... effect…
Objective: To evaluate the association of bone turnover biomarkers with blood levels of alkaline phosphatase (ALP), bone-specific alkaline phosphatase (BAP), osteocalcin (OC), tartrate-resistant acid phosphatase (TRAP)…
also other macros- and micronutrients offer today potential benefits to optimize bone health. Bone turnover makers are today an accepted means to determine the efficacy of nutritional intervention before ... with…
Paget’s disease is characterized by increased bone turnover, and treatment has been revolutionized by the introduction of bisphosphonates. Zoledronic acid is the latest compound to be introduced into clinical…
Background: Variety of growth factors and cytokines are involved in the process of bone turnover. Evidences are showing that alterations in OPG/RANK/RANKL system form the basis of many ... significantly correlated with…
involving the coupled processes of resorption and formation. Biochemical markers reflect acute changes in bone turnover and are, therefore, useful to measure the effects of short-term nutritional interventions ... bone…
intervention, on (a) hip and spine bone mineral density (aBMD), and (b) biomarkers of bone turnover, in older adults with obesity. Methods: 37 older (70.1 ± 3.0 years) adults with obesity ... acquired aBMD of the total…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.